Publication

Performance of Serum microRNAs-122,-192 and-21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis

Related publications (32)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Performance of Serum microRNAs-122,-192 and-21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis

Graph Chatbot

Chat with Graph Search

Small Heterodimer Partner Deletion Prevents Hepatic Steatosis and When Combined With Farnesoid X Receptor Loss Protects Against Type 2 Diabetes in Mice

Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease

Microencapsulation of hepatocytes and mesenchymal stem cells for therapeutic applications

Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in LdIr(-/-) Mice

Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis

The Receptor TGR5 Protects the Liver From Bile Acid Overload During Liver Regeneration in Mice

The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection

Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets

Aggravation of viral hepatitis by platelet-derived serotonin

Magnetic resonance elastography for the noninvasive staging of liver fibrosis